Fraunhofer relies on automation technologies in medical research

News /

As a pioneer in applied research, the Fraunhofer-Gesellschaft is bringing together the expertise of 23 Fraunhofer institutions to develop new development and production technologies for innovative cell and gene therapeutics, as well as vaccines, in the “Production for Intelligent Medicine” innovation cluster. As a first step of the project, a concept for a modular pilot plant for the automatic production of these therapeutics is to be developed, combining both Industry 4.0 and Health 4.0. Fraunhofer ITEM is collaborating in this project and will be involved in designing the production and quality control of ATMPs (Advanced Therapy Medicinal Products) and vaccines.